Literature DB >> 8302598

Polymorphism at codon 36 of the p53 gene.

C A Felix1, D L Brown, T Mitsudomi, N Ikagaki, A Wong, R Wasserman, R B Womer, J A Biegel.   

Abstract

A polymorphism at codon 36 in exon 4 of the p53 gene was identified by single strand conformation polymorphism (SSCP) analysis and direct sequencing of genomic DNA PCR products. The polymorphic allele, present in the heterozygous state in genomic DNAs of four of 100 individuals (4%), changes the codon 36 CCG to CCA, eliminates a FinI restriction site and creates a BccI site. Including this polymorphism there are four known polymorphisms in the p53 coding sequence.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302598

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene.

Authors:  Neeme Tõnisson; Jana Zernant; Ants Kurg; Hendrik Pavel; Georg Slavin; Hanno Roomere; Aune Meiel; Pierre Hainaut; Andres Metspalu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.

Authors:  Md Shaki Mostaid; Maizbha Uddin Ahmed; Mohammad Safiqul Islam; Muhammad Shahdaat Bin Sayeed; Abul Hasnat
Journal:  Tumour Biol       Date:  2014-07-18

3.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 4.  A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.

Authors:  Golap Babu; Shad Bin Islam; Md Asaduzzaman Khan
Journal:  Mol Biol Rep       Date:  2022-03-11       Impact factor: 2.742

Review 5.  Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.

Authors:  Roman Hrstka; Philip J Coates; Borivoj Vojtesek
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.